Yeah.....
What does an investor pay for a fin tech thats reached it's used by date on growth? 20 times EBIT? Certainly not 200 times EBIT....
let alone any adverse regulatory findings.
- Forums
- ASX - By Stock
- SP1
- something different to talk about
something different to talk about, page-5
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SP1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online